EA201201050A1 - Пиразолы в качестве антагонистов crth2 - Google Patents
Пиразолы в качестве антагонистов crth2Info
- Publication number
- EA201201050A1 EA201201050A1 EA201201050A EA201201050A EA201201050A1 EA 201201050 A1 EA201201050 A1 EA 201201050A1 EA 201201050 A EA201201050 A EA 201201050A EA 201201050 A EA201201050 A EA 201201050A EA 201201050 A1 EA201201050 A1 EA 201201050A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- pyrazoles
- compounds
- crth2
- antagonists
- antagonists crth2
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Otolaryngology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
Abstract
Настоящее изобретение относится к пиразолам формулы (I) и их фармацевтически приемлемым солям, обладающим активностью в отношении CRTH2, где значения W, L, L, X, L, Y, Rи Rявляются такими, как определено в описании и формуле изобретения, к применению указанных соединений в качестве лекарственных средств и к фармацевтическим составам, содержащим указанные соединения или содержащим комбинацию указанных соединений с одним или более активных веществ.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10151785 | 2010-01-27 | ||
PCT/EP2011/050910 WO2011092140A1 (en) | 2010-01-27 | 2011-01-24 | Pyrazole compounds as crth2 antagonists |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201201050A1 true EA201201050A1 (ru) | 2013-02-28 |
EA022280B1 EA022280B1 (ru) | 2015-12-30 |
Family
ID=42112128
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201201050A EA022280B1 (ru) | 2010-01-27 | 2011-01-24 | Пиразолы в качестве антагонистов crth2 |
Country Status (37)
Country | Link |
---|---|
US (1) | US8791272B2 (ru) |
EP (1) | EP2528901B9 (ru) |
JP (1) | JP5658284B2 (ru) |
KR (2) | KR101906791B1 (ru) |
CN (3) | CN104829535A (ru) |
AP (1) | AP3360A (ru) |
AR (1) | AR080032A1 (ru) |
AU (1) | AU2011209286B2 (ru) |
BR (1) | BR112012018695A2 (ru) |
CA (1) | CA2788224C (ru) |
CL (1) | CL2012001836A1 (ru) |
CO (1) | CO6511272A2 (ru) |
CY (1) | CY1116641T1 (ru) |
DK (1) | DK2528901T3 (ru) |
EA (1) | EA022280B1 (ru) |
ES (1) | ES2545865T3 (ru) |
GE (1) | GEP20146177B (ru) |
HK (1) | HK1176062A1 (ru) |
HR (1) | HRP20150898T1 (ru) |
HU (1) | HUE025318T2 (ru) |
IL (1) | IL220208A (ru) |
MA (1) | MA33937B1 (ru) |
MX (1) | MX353000B (ru) |
MY (1) | MY160036A (ru) |
NZ (1) | NZ600637A (ru) |
PE (1) | PE20121519A1 (ru) |
PL (1) | PL2528901T3 (ru) |
PT (1) | PT2528901E (ru) |
RS (1) | RS54176B1 (ru) |
SG (1) | SG182684A1 (ru) |
SI (1) | SI2528901T1 (ru) |
TN (1) | TN2012000371A1 (ru) |
TW (1) | TWI499416B (ru) |
UA (1) | UA110025C2 (ru) |
UY (1) | UY33201A (ru) |
WO (1) | WO2011092140A1 (ru) |
ZA (1) | ZA201204335B (ru) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2545865T3 (es) | 2010-01-27 | 2015-09-16 | Boehringer Ingelheim International Gmbh | Compuestos de pirazol como antagonistas de CRTH2 |
BR112013012836A2 (pt) * | 2010-11-24 | 2019-09-24 | Allergan Inc | moduladores dos receptores s1p" |
US8759386B2 (en) * | 2011-01-24 | 2014-06-24 | Boehringer Ingelheim International Gmbh | Pyrazole compounds as CRTH2 antagonists |
CN103113303A (zh) * | 2011-11-16 | 2013-05-22 | 山东亨利医药科技有限责任公司 | 作为crth2受体拮抗剂的氮杂环化合物 |
HUE042655T2 (hu) * | 2011-11-17 | 2019-07-29 | Kbp Biosciences Co Ltd | Nitrogént tartalmazó kondenzált gyûrûs vegyületek CRTH2 antagonistaként történõ alkalmazásra |
AU2012362724C1 (en) * | 2011-12-27 | 2018-01-18 | Allergan, Inc. | Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response |
CN104662018B (zh) | 2012-04-20 | 2017-10-24 | 阿迪维纳斯治疗有限公司 | 取代的杂双环化合物、组合物及其医疗应用 |
US20140148484A1 (en) * | 2012-11-23 | 2014-05-29 | Boehringer Ingelheim International Gmbh | Pyrazole compounds for treating hairloss |
WO2014138979A1 (en) | 2013-03-13 | 2014-09-18 | Canadian Blood Services | Pyrazole derivatives and their uses thereof |
CN103265537B (zh) * | 2013-05-14 | 2015-05-27 | 浙江医药高等专科学校 | 抗肿瘤化合物、其制备方法和用途 |
CN103265535B (zh) * | 2013-05-14 | 2015-06-17 | 浙江医药高等专科学校 | 抗肿瘤化合物、其制备方法和用途 |
AU2015308350B2 (en) | 2014-08-29 | 2020-03-05 | Tes Pharma S.R.L. | Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase |
LT3762368T (lt) | 2018-03-08 | 2022-06-10 | Incyte Corporation | Aminopirazindiolio junginiai, kaip pi3k-γ inhibitoriai |
WO2020010003A1 (en) | 2018-07-02 | 2020-01-09 | Incyte Corporation | AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS |
US11034669B2 (en) | 2018-11-30 | 2021-06-15 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
CR20210605A (es) | 2019-06-06 | 2022-01-07 | Basf Se | N-(prid-3-il)carboxamidas fungicidas |
WO2021063735A1 (en) | 2019-10-02 | 2021-04-08 | Basf Se | New bicyclic pyridine derivatives |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4828914B1 (ru) * | 1969-04-11 | 1973-09-05 | ||
US4146721A (en) * | 1969-09-12 | 1979-03-27 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Pyrazol-4-acetic acid compounds |
BE759032A (fr) * | 1969-11-17 | 1971-04-30 | Takeda Chemical Industries Ltd | Acide 3,5-diphenyl-4-pyrazole acetique ou ses derives 1-substitues ou leurs esters |
US5260322A (en) | 1990-10-08 | 1993-11-09 | Merck & Co., Inc. | Angiotension II antagonists in the treatment of hyperuricemia |
US7179823B1 (en) * | 1999-11-10 | 2007-02-20 | Takeda Pharmaceutical Company Limited | 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
JP2002348281A (ja) * | 2001-03-23 | 2002-12-04 | Takeda Chem Ind Ltd | 5員複素環アルカン酸誘導体 |
JP2003073377A (ja) * | 2001-06-20 | 2003-03-12 | Takeda Chem Ind Ltd | 5員複素環誘導体 |
WO2003026663A1 (en) * | 2001-09-25 | 2003-04-03 | Pharmacia Corporation | Process for making substituted pyrazoles |
MXPA05003456A (es) * | 2002-10-04 | 2005-07-05 | Millennium Pharm Inc | Antagonistas del receptor de pgd2 para el tratamiento de enfermedades inflamatorias. |
ES2257616T3 (es) | 2003-04-25 | 2006-08-01 | Actimis Pharmaceuticals, Inc. | Derivados del acido pirimidinilacetico utiles para el tratamiento de enfermedades mediadas por crth2. |
US20070060596A1 (en) | 2003-10-24 | 2007-03-15 | Giblin Gerard M P | Heterocyclyl compounds |
GB0525141D0 (en) * | 2005-12-09 | 2006-01-18 | Novartis Ag | Organic compounds |
GB0525144D0 (en) * | 2005-12-09 | 2006-01-18 | Novartis Ag | Organic compounds |
DE602007010781D1 (de) | 2006-06-06 | 2011-01-05 | Glaxo Group Ltd | N- (phenylmethyl) -2- (1h-pyrazol-4-yl) acetamid-derivate als p2x7-antagonisten zur behandlung von schmerzen, entzündungen und neurodegeneration |
US20110046137A1 (en) | 2007-05-10 | 2011-02-24 | Glaxo Group Limited | Pyrazole Derivatives as P2X7 Modulators |
CL2008002827A1 (es) | 2007-09-25 | 2009-11-27 | Actimis Pharmaceuticals Inc | Compuestos derivados de 2-s-bencil pirimidina, antagonistas del receptor crth2; composicion farmaceutica que los comprende; y su uso en el tratamiento de enfermedades alergicas mediadas por eosinofilos y basofilos, tales como asma, rinitis alergica, dermatitis atopica, conjuntivitis alergica, sinusitis y psoriasis, entre otras |
MX2010003182A (es) * | 2007-09-25 | 2010-06-02 | Actimis Pharmaceuticals Inc | Alquiltiopirimidinas como antagonistas de crth2. |
GB0719521D0 (en) * | 2007-10-05 | 2007-11-14 | Argenta Discovery Ltd | Compounds |
US8293917B2 (en) * | 2008-05-06 | 2012-10-23 | Boehringer Ingelheim International Gmbh | Pyrazole compounds as CCR1 antagonists |
ES2378755T3 (es) * | 2008-07-15 | 2012-04-17 | F. Hoffmann-La Roche Ag | �?cidos aminotetrahidroindazoloacéticos |
ES2545865T3 (es) | 2010-01-27 | 2015-09-16 | Boehringer Ingelheim International Gmbh | Compuestos de pirazol como antagonistas de CRTH2 |
-
2011
- 2011-01-24 ES ES11701796.2T patent/ES2545865T3/es active Active
- 2011-01-24 JP JP2012550408A patent/JP5658284B2/ja not_active Expired - Fee Related
- 2011-01-24 US US13/012,244 patent/US8791272B2/en not_active Expired - Fee Related
- 2011-01-24 DK DK11701796.2T patent/DK2528901T3/en active
- 2011-01-24 SI SI201130571T patent/SI2528901T1/sl unknown
- 2011-01-24 UA UAA201210049A patent/UA110025C2/uk unknown
- 2011-01-24 PT PT117017962T patent/PT2528901E/pt unknown
- 2011-01-24 MY MYPI2012003353A patent/MY160036A/en unknown
- 2011-01-24 SG SG2012054599A patent/SG182684A1/en unknown
- 2011-01-24 NZ NZ600637A patent/NZ600637A/en not_active IP Right Cessation
- 2011-01-24 WO PCT/EP2011/050910 patent/WO2011092140A1/en active Application Filing
- 2011-01-24 AU AU2011209286A patent/AU2011209286B2/en not_active Ceased
- 2011-01-24 KR KR1020177036287A patent/KR101906791B1/ko active IP Right Grant
- 2011-01-24 CA CA2788224A patent/CA2788224C/en not_active Expired - Fee Related
- 2011-01-24 MX MX2012008361A patent/MX353000B/es active IP Right Grant
- 2011-01-24 PE PE2012001022A patent/PE20121519A1/es active IP Right Grant
- 2011-01-24 CN CN201510197776.1A patent/CN104829535A/zh active Pending
- 2011-01-24 MA MA35081A patent/MA33937B1/fr unknown
- 2011-01-24 KR KR1020127019807A patent/KR101812000B1/ko active IP Right Grant
- 2011-01-24 RS RS20150539A patent/RS54176B1/en unknown
- 2011-01-24 BR BR112012018695A patent/BR112012018695A2/pt not_active Application Discontinuation
- 2011-01-24 CN CN201810431471.6A patent/CN108383789A/zh active Pending
- 2011-01-24 EP EP11701796.2A patent/EP2528901B9/en active Active
- 2011-01-24 CN CN201180016294.1A patent/CN102884051B/zh not_active Expired - Fee Related
- 2011-01-24 GE GEAP201112849A patent/GEP20146177B/en unknown
- 2011-01-24 PL PL11701796T patent/PL2528901T3/pl unknown
- 2011-01-24 EA EA201201050A patent/EA022280B1/ru not_active IP Right Cessation
- 2011-01-24 HU HUE11701796A patent/HUE025318T2/en unknown
- 2011-01-24 AP AP2012006313A patent/AP3360A/xx active
- 2011-01-25 UY UY0001033201A patent/UY33201A/es not_active Application Discontinuation
- 2011-01-26 AR ARP110100257A patent/AR080032A1/es active IP Right Grant
- 2011-01-26 TW TW100102949A patent/TWI499416B/zh not_active IP Right Cessation
-
2012
- 2012-06-06 IL IL220208A patent/IL220208A/en not_active IP Right Cessation
- 2012-06-13 ZA ZA2012/04335A patent/ZA201204335B/en unknown
- 2012-07-06 CL CL2012001836A patent/CL2012001836A1/es unknown
- 2012-07-23 TN TNP2012000371A patent/TN2012000371A1/en unknown
- 2012-07-27 CO CO12126467A patent/CO6511272A2/es active IP Right Grant
-
2013
- 2013-03-19 HK HK13103377.2A patent/HK1176062A1/zh not_active IP Right Cessation
-
2015
- 2015-08-20 CY CY20151100728T patent/CY1116641T1/el unknown
- 2015-08-26 HR HRP20150898TT patent/HRP20150898T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201201050A1 (ru) | Пиразолы в качестве антагонистов crth2 | |
CY1123365T1 (el) | Ενωσεις που εχουν δραστικοτητα ανταγωνιστη μουσκαρινικου υποδοχεα και αγωνιστη βητα2 αδρενεργικου υποδοχεα | |
EA201401351A1 (ru) | Производные бензимидазол-пролина | |
UA108640C2 (ru) | Производные n-(имидазопиримидин 7-ил) гетероариламидов и их применение в качестве ингибиторов pde10a | |
TR201904614T4 (tr) | Novel pyrazole derivative. | |
EA201291282A1 (ru) | Азотсодержащие гетероарильные соединения | |
BR112015000704A2 (pt) | imidazotriazinacarbonitrilas úteis como inibidores de quinase | |
EA201300200A1 (ru) | N-((6-аминопиридин-3-ил)метил)гетероарилкарбоксамиды в качестве ингибиторов калликреина в плазме | |
EA201300684A1 (ru) | Производные 6-амино-2-фениламино-1н-бензимидазол-5-карбоксамида и их применение в качестве ингибиторов микросомной простагландин-е2-синтазы-1 | |
MX336381B (es) | Boronatos como inhibidores de arginasa. | |
EA201400771A1 (ru) | Новые производные азетидина, фармацевтические композиции и их применение | |
EA201270216A1 (ru) | Фармацевтический состав | |
EA201190320A1 (ru) | Гетероциклические сульфонамиды, их применения и фармацевтические композиции | |
EA201390799A1 (ru) | Триазолопиридины | |
EA201490599A1 (ru) | Соединения триазолопиридина в качестве ингибиторов фосфодиэстеразы pde10a | |
EA201400822A1 (ru) | Производные гетероциклических амидов в качестве антагонистов p2xрецептора | |
TR201902057T4 (tr) | Tetrasiklin bileşikleri. | |
PH12018501531A1 (en) | Pyrazole compounds as crth2 antagonists | |
EA201501163A1 (ru) | Модуляторы рецептора cxcr7 | |
EA201591175A1 (ru) | Трициклические соединения в качестве ингибиторов cftr | |
MX2014014308A (es) | Pirrolidino heterociclos. | |
CO6592109A2 (es) | Nueva forma cristalina de un derivado de ciclopropilbenzamida | |
EA201290229A1 (ru) | Производные спиролактама и их применение | |
EA201490573A1 (ru) | Соединение бензотиазолона | |
EA201291401A1 (ru) | НОВЫЕ ПРОТИВОГРИБКОВЫЕ ПРОИЗВОДНЫЕ 5,6-ДИГИДРО-4-[(ДИФТОРЭТИЛ)ФЕНИЛ]-4H-ПИРРОЛО[1,2-a][1,4]БЕНЗОДИАЗЕПИНА И 4-(ДИФТОРЭТИЛ)ФЕНИЛ-6H-ПИРРОЛО[1,2-a][1,4]БЕНЗОДИАЗЕПИНА |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ KG MD TJ TM |
|
PC4A | Registration of transfer of a eurasian patent by assignment | ||
PD4A | Registration of transfer of a eurasian patent in accordance with the succession in title |